Effects of Progressive Neck Motor Control Exercises With and Without Conventional Therapy in Text Neck Syndrome.(PNMCE-TNS) (Yes)

November 13, 2026 updated by: Salman Bashir, University of Management and Technology Lahore

Effects of Progressive Neck Motor Control Exercises With and Without Conventional Therapy on Pain, Range of Motion, Posture and Function Among Patients With Text Neck Syndrome

This study aims to compare the effects of Progressive Neck Motor Control Exercises (PNMCE) with and without conventional physiotherapy in patients with Text Neck Syndrome. It will evaluate the effectiveness of both treatment approaches in reducing neck pain, improving cervical range of motion, correcting posture, and enhancing functional ability. The study will determine which treatment approach provides better clinical outcomes.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • University of Management & Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals aged 18-40 years of both gender

    • Text Neck Syndrome confirmed by: daily smartphone/tablet use ≥ 4 hours
    • AND neck pain onset linked to device use for a minimum of 3 months.
    • Forward Head Posture confirmed by craniovertebral angle (CVA) <50° on standardised photographic assessment.
    • Neck pain intensity ≥ 4 on the Numerical Pain Rating Scale (NPRS).

Exclusion Criteria:

  • Cognitive impairment limiting ability to follow instructions.

    • Use of cervical orthosis or splint devices.
    • Diagnosed systematic joint or muscle disease (e.g., fibromyalgia, rheumatoid arthritis).
    • Serious systemic diseases or neurological disorders (e.g., cervical radiculopathy, myelopathy,trigeminal neuralgia).
    • Pregnancy or breastfeeding.
    • History of surgery or significant trauma to the cervical region.
    • Positive vertebrobasilar artery test.
    • Confirmed cervical fracture or congenital cervical deformity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Progressive Neck Motor Control Exercises with conventional Therapy

Participants will receive conventional physiotherapy, including hot pack and TENS application (15 minutes), cervical joint mobilization (Maitland Grades I-III, 3 sets of 30 seconds per segment), and soft tissue mobilization/myofascial release of the upper trapezius, levator scapulae, and sternocleidomastoid (10 minutes). Postural correction and ergonomic education will be provided, followed by the full PNMCE program.

Participants will receive conventional physiotherapy, including hot pack and TENS application (15 minutes), cervical joint mobilization (Maitland Grades I-III, 3 sets of 30 seconds per segment), and soft tissue mobilization/myofascial release of the upper trapezius, levator scapulae, and sternocleidomastoid (10 minutes). Postural correction and ergonomic education will be provided, followed by the full PNMCE program.

Active Comparator: Progressive Neck Motor Control Exercises with Patient Education

Participants will receive patient education on disease management, diet, activity modification, and posture, followed by a 6-week Progressive Neck Muscle Control Exercise (PNMCE) program.

Weeks 1-2: Supine/prone chin tucks, craniocervical flexion (20-22 mmHg), and upper/lower limb exercises; Weeks 3-4: Quadrupedal/standing chin tucks, limb exercises, wall angels, and craniocervical flexion (24-26 mmHg).

Weeks 5-6: Swiss ball exercises, resisted chin tucks, and upper limb strengthening with TheraBand (red to green to blue), progressing to 28-30 mmHg; all exercises performed for 2 sets of 10 repetitions, with resistance increased according to tolerance.

Participants will receive patient education on disease management, diet, activity modification, and posture, followed by a 6-week Progressive Neck Muscle Control Exercise (PNMCE) program.

Weeks 1-2: Supine/prone chin tucks, craniocervical flexion (20-22 mmHg), and upper/lower limb exercises; Weeks 3-4: Quadrupedal/standing chin tucks, limb exercises, wall angels, and craniocervical flexion (24-26 mmHg).

Weeks 5-6: Swiss ball exercises, resisted chin tucks, and upper limb strengthening with TheraBand (red to green to blue), progressing to 28-30 mmHg; all exercises performed for 2 sets of 10 repetitions, with resistance increased according to tolerance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: Baseline and six weeks post treatment

11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain

Baseline and six weeks post treatment
Universal Goniometer
Time Frame: Baseline and six weeks post treatment

Cervical range of motion (ROM) will be assessed using a universal goniometer in sagittal, frontal, and transverse planes. Measurements will be taken in sitting with the thoracic spine stabilized, except rotation (supine), using anatomical landmarks (tragus, occiput, acromion, and C7). Three trials per direction will be averaged with 30-second rest intervals

Baseline and six weeks post treatment
Craniovertebral Angle Photographic Analysis
Time Frame: Baseline and six weeks post treatment

Head and neck posture will be assessed using standardised photographic methods consistent with those described in the reference study. The tragus, pogonion, eye corner, and acromion process are anatomical features that will be delineated at C7. A digital camera will be placed three meters away from the subject at shoulder height, and image analysis software will be used to determine the CVA.

Baseline and six weeks post treatment
Neck Disability Index
Time Frame: Baseline and six weeks post treatment

0-8% indicates no disability, 10-28% indicates mild disability, 30-48% indicates moderate impairment, 50-64% indicates severe disability, and ≥65% indicates complete disability. The total scores range from 0 to 50 and are converted to percentages.

Baseline and six weeks post treatment
Aneroid Sphygmomanometer
Time Frame: Baseline and six weeks post treatment

To simplify and track craniocervical flexion exercises for deep cervical flexor muscle training, a modified aneroid sphygmomanometer is employed as a pressure biofeedback tool. The sphygmomanometer inflatable bladder was placed under the cervical lordosis and inflated to a baseline pressure of 20 mmHg. There is evidence that the Craniocervical Flexion Test (CCFT) has excellent reliability and acceptable validity when using a modified aneroid sphygmomanometer.

Baseline and six weeks post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 20, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 17, 2026

First Submitted That Met QC Criteria

October 17, 2026

First Posted (Actual)

October 23, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

6 months after the publication of the manuscript.

IPD Sharing Access Criteria

This data can be requested from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe